Cytoplasmic superoxide radical: a possible contributing factor to intracellular Aβ oligomerization in Alzheimer disease
- PMID: 22896786
- PMCID: PMC3419108
- DOI: 10.4161/cib.19548
Cytoplasmic superoxide radical: a possible contributing factor to intracellular Aβ oligomerization in Alzheimer disease
Abstract
Soluble amyloid β (Aβ) oligomers cause memory loss and synaptic dysfunction in Alzheimer disease (AD). Despite intensive studies on Aβ assembly in vitro and in vivo, the localization and cellular mechanism of Aβ oligomerization are not fully understood. Previously, we demonstrated that cytoplasmic superoxide radicals contribute to drusen deposition, a hallmark of age-related macular degeneration as well as other geriatric diseases (fatty liver, skin thinning, and osteoporosis). Using a transgenic mouse model of AD, we recently clarified the role of cytoplasmic oxidative stress in cognitive impairment and oligomer formation. Moreover, we also found that these phenomena were associated with neuroinflammation, tau phosphorylation, and synaptic loss. Notably, studies using human brains support the involvement of cytoplasmic superoxide radicals in AD pathology. In this addendum to Murakami et al. (JBC 2011), we discuss and comment on intracellular Aβ oligomer formation and the possible therapeutic effects of intracellular redox state modulators.
Keywords: Alzheimer’s disease; SOD; amyloid β; memory loss; oligomer; oxidative stress; superoxide radical.
Figures

Similar articles
-
SOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid β protein oligomerization and memory loss in mouse model of Alzheimer disease.J Biol Chem. 2011 Dec 30;286(52):44557-68. doi: 10.1074/jbc.M111.279208. Epub 2011 Nov 9. J Biol Chem. 2011. PMID: 22072713 Free PMC article.
-
Stimulation of the amyloidogenic pathway by cytoplasmic superoxide radicals in an Alzheimer's disease mouse model.Biosci Biotechnol Biochem. 2012;76(6):1098-103. doi: 10.1271/bbb.110934. Epub 2012 Jun 7. Biosci Biotechnol Biochem. 2012. PMID: 22790929
-
Vitamin C restores behavioral deficits and amyloid-β oligomerization without affecting plaque formation in a mouse model of Alzheimer's disease.J Alzheimers Dis. 2011;26(1):7-18. doi: 10.3233/JAD-2011-101971. J Alzheimers Dis. 2011. PMID: 21558647
-
[Involvement of beta-amyloid in the etiology of Alzheimer's disease].Brain Nerve. 2010 Jul;62(7):691-9. Brain Nerve. 2010. PMID: 20675873 Review. Japanese.
-
Therapeutic Strategies Targeting Amyloid-β in Alzheimer's Disease.Curr Alzheimer Res. 2019;16(5):418-452. doi: 10.2174/1567205016666190321163438. Curr Alzheimer Res. 2019. PMID: 30907320 Review.
Cited by
-
The Small Molecule GAL-201 Efficiently Detoxifies Soluble Amyloid β Oligomers: New Approach towards Oral Disease-Modifying Treatment of Alzheimer's Disease.Int J Mol Sci. 2022 May 21;23(10):5794. doi: 10.3390/ijms23105794. Int J Mol Sci. 2022. PMID: 35628602 Free PMC article.
-
Scotopic microperimetry in the early diagnosis of age-related macular degeneration: preliminary study.Biomed Res Int. 2014;2014:671529. doi: 10.1155/2014/671529. Epub 2014 Dec 9. Biomed Res Int. 2014. PMID: 25548774 Free PMC article.
-
Vitamin C, Aging and Alzheimer's Disease.Nutrients. 2017 Jun 27;9(7):670. doi: 10.3390/nu9070670. Nutrients. 2017. PMID: 28654021 Free PMC article. Review.
-
Preventing expression of the nicotinic receptor subunit α7 in SH-SY5Y cells with interference RNA indicates that this receptor may protect against the neurotoxicity of Aβ.Neurochem Res. 2013 May;38(5):943-50. doi: 10.1007/s11064-013-1001-8. Epub 2013 Feb 21. Neurochem Res. 2013. PMID: 23430468
-
S-Nitrosylation in Alzheimer's disease.Mol Neurobiol. 2015 Feb;51(1):268-80. doi: 10.1007/s12035-014-8672-2. Epub 2014 Mar 25. Mol Neurobiol. 2015. PMID: 24664522 Review.
References
LinkOut - more resources
Full Text Sources